Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation

Journal of Veterinary Internal Medicine

Volumn 16, Issue 1, 2002, Pages 80-88

  Kvart, Clarence ^a   Häggström, Jens ^a   Pedersen, Henrik Duelund ^b   Hansson, Kerstin ^a   Eriksson, Anders ^c   Järvinen, Anna Kaisa ^c   Tidholm, Anna ^e   Bsenko, Karina ^g   Ahlgren, Erik ^g   Ilves, Mikael ^h   Åblad, Björn ⁱ   Falk, Torkel ^j   Bjerkås, Ellen ^d   Gundler, Susanne ^f   Lord, Peter ^a   Wegeland, Gudrun ^k   Adolfsson, Eva ^l   Corfitzen, Jens ^m  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^e Albano Animal Hospital   (Sweden)

^f Bagarmossen Animal Hospital   (Sweden)

^g Sandviken Animal Hospital   (Sweden)

^h Hau Mau Animal Clinic   (Finland)

ⁱ Blå Stjarnan Animal Hospital   (Sweden)

^j Helsingborg Animal Hospital   (Sweden)

^k Örnsköldsvik Hospital   (Sweden)

^l Strömsholms Animal Hospital   (Sweden)

^m Middelfart Hospital   (Denmark)

more..

Author keywords

Angiotensin converting enzyme inhibitor; Canine; Myxomatous mitral valve disease; Preventive cardiac therapy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOG; DOG DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HOSPITALIZATION; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; MALE; MITRAL VALVE INSUFFICIENCY; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; SCANDINAVIA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036357934     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2002.tb01610.x     Document Type: Article

References (39)

1. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:725-727.
2. The CONSENSUS Trial Study Group. Effect of Enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316: 1429-1435.
3. The IMPROVE Study Group. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: Results of the Invasive Multicenter Prospective veterinary evaluation of enalapril study. J Vet Intern Med 1995;9:234-242.
4. The COVE study group. Controlled clinical evaluation of enalapril in dogs with heart failure. Results of the cooperative veterinary enalapril study group. J Vet Intern Med 1995;9:243-252.
5. Ettinger SJ, Benitz AM, Ericsson GF, et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapnl (LIVE) Study Group. J Am Vet Med Assoc 1998;213:1573-1577.
6. Kitagawa H, Wakamiya H, Kitoh K, et al. Efficacy of monotherapy with benazeprtl, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency. J Vet Med Sci 1997;59:513-520.
7. The BENCH (BENazepril in Canine Heart Disease) Study Group. The effect of benazepnl on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter. prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1999;1:7-18.
8. Kolm U. Kosztolich A Therapie des herzinsuffizienten hundes mittels benazepril-HCL (Fonekor): Ergebnisse einer langzeitsmdie: Klinischer Verlauf und elektrokardiographische kontrolle Wien Tierärztl Mschr 1999;86:289-300.
9. Pedersen HD, Koch J. Poulsen K, et al. Activation of the reninangiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J Vet Intern Med 1995;9:328-333.
10. Brilla C, Maisch B. Regulation of the structural remodelling of the myocardium: From hypertrophy to heart failure. Eur Heart J 1994; 15:45-52
11. Cleland S, Reid J. The renin-angiotensin system and the heart: A historical review. Heart 1996;76:7-12.
12. Lee M, Bohm M, Paul M, et al. Tissue renin-angiotensm systems: Their role in cardiovascular disease? Circulation 1993;87(Suppl 5):7-13.
13. Lindpaintner K, Wilhelm M, Jin T, et al. Tissue renin-angiotensin systems: Focus on the heart J Hypertens 1987;5:33-38
14. Häggström J. Chronic Valvular Disease in Cavalier King Charles Spaniels - Epidemiology, Inheritance and Pathophysiology. Uppsala, Sweden: Swedish University of Agricultural Sciences; 1996. Thesis.
15. Tidholm A. Canine idiopathic dilated cardiomyopathy - Epidemiology, Histopathology and Pathophysiology. Uppsala: Swedish University of Agricultural Sciences, 2000. Thesis.
16. Kvart C, Häggström J, Pedersen HD. ACE inhibition in asymptomatic MR dogs: Results from a 4 year prospective, double blind, placebo controlled, monotherapy trial. Proceedings of the 18th Annual ACVIM Forum. 2000:137-138 (abstract).
17. Kvart C, Häggström J. ACE inhibition and mitral valve disease. Proceedings of the 17th Annual ACVIM Forum. 1999:83-84 (abstract).
18. Häggström J, Hansson K, Kvart C. Heart sounds and murmurs: Changes related to severity of mitral régurgitation in Cavalier King Charles Spaniels. J Vet Intern Med 1995;9:75-83.
19. Suter PF, Lord PF. Thoracic Radiography, text atlas of thoracic diseases of the dog and cat. Wettswil, Switzerland: Selbstverlag PF Suter; 1984:24-43, 100-113, 480-497, 551-575.
20. Concato J, Shah N, Horwitz R. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.
21. Pedersen HD, Olsen LH, Mow T, Christensen NT. Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions Res Vet Sci 1999;66:11-17.
22. Häggström J, Hansson K, Kvart C, et al. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res 1997;58:77-82.
23. Tidholm A, Häggström J, Hansson K. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs. Am J Vet Res 2001;62:961-967.
24. Koch J, Pedersen HD, Jensen AL, et al. Activation of the reninangiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy. Res Vet Sci 1995;59:172-175.
25. Mow T, Pedersen HD. No expression of angiotensin II receptors and angiotensin-converting enzyme in myxomatous canine mitral valve leaflets. An autoradiographic study. J Vet Med Ser A 1999;46: 465-472.
26. Dell'italia L, Balcells E, Meng Q, et al Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol 1997;273:H961-H970.
27. Haggström J, Hansson K, Karlberg B, et al. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Am J Vet Res 1996,57:1645-1652.
28. Kittleson M. Therapy of heart failure. In: Ettinger SJ, Feldman EC, ed. Textbook of Veterinary Internal Medicine, 5th ed. Philadelphia. PA: WB Saunders; 2000:718.
29. Pedersen HD, Häggström J, Falk T, et al Auscultation in mild mitral regurgitation in dogs: Observer variation, effects of physical maneuvers, and agreement with color Doppler echocardiography and phonocardiography. J Vet Intern Med 1999; 13:56-64.
30. Detweiler DK, Pattersson DF. The prevalence and types of cardiovascular disease in dogs. Ann N Y Acad Sci 1965;127.481-516.
31. Swenson L, Häggström J, Kvart J, et al. Relationship between parental cardiac status in Cavalier King Charles Spaniels and prevalence and severity of chronic valvular disease in offspring. J Am Vet Med Absoc 1996;208:2009-2012.
32. Olsen LH, Fredholm M, Pedersen HD. Epidemiology and inheritance of mitral valve prolapse in Dachshunds. J Vet Intern Med 1999;13:448-456.
33. Klein J, Moeschberger M. Censoring and truncation. In: Survival Analysis. New York, NY: Springer-Verlag; 1997:55-79.
34. Hamlin R, Benitz A, Erickson G, et al. Effects of Enalapril on exercise tolerance and longevity in dogs with heart failure produced by iatrogenic mitral regurgitation. J Vet Intern Med 1997;10:85-87.
35. Hamlin R, Nakayama T. Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles. J Vet Intern Med 1998;12:93-95.
36. Miura S, Ideishi M, Sakai T, et al. Angiotensin II formation by an alternative pathway during exercise in humans. J Hypertens 1994; 12:1177-1181.
37. Balcells E, Meng Q, Hageman G, et al. Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro. Am J Physiol 1996;271:H417-H421
38. Ettinger SJ, Suter PE Acquired valvular and endocardial heart disease. In: Canine Cardiology Philadelphia, PA: WB Saunders; 1970: 324-325.
39. Fischler M, Follath F. Comparative aspects of ACE-inhibitors: What differences are relevant Schweiz Med Wochenschr 1999;129: 1053-1060.